Interferon Beta Drugs for Multiple Sclerosis - WebMD
2024年3月6日 · Interferon beta medications help make your disease get worse less often, and they stabilize the course of the disease. They might also slow down how quickly symptoms get worse and...
Beta interferons | MS Society
Beta interferons are disease modifying therapies (DMTs) for relapsing MS and in some cases secondary progressive MS. Their brand names are Avonex, Plegridy and Rebif and they are all taken as injections.
Interferons in the Treatment of Multiple Sclerosis - PubMed …
Interferon beta (IFNβ) was the first disease-modifying therapy available to treat multiple sclerosis (MS), providing patients with a treatment that resulted in reduced relapse rates and delays in the onset of disability.
Interferon beta-1a: Uses, Dosage, Side Effects, Warnings - Drugs.com
2025年1月2日 · Interferon beta-1a is used to treat relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Brand names of interferon beta …
Interferon - StatPearls - NCBI Bookshelf
2023年7月10日 · Interferons are currently used clinically to treat viral infections such as hepatitis C, cancers including non-Hodgkin’s lymphoma, and autoimmune diseases such as multiple sclerosis. This activity outlines the different types of interferons, namely interferon alpha, beta, …
Interferon beta-1a - Wikipedia
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS). [5] . It is produced by mammalian cells, while interferon beta-1b is produced in modified E. coli. [6] Some research indicates that interferon injections may result in an 18–38% reduction in the rate of MS relapses. [7]
Beta-Interferons Medication for MS | Overcoming MS
Beta-Interferons for MS. Interferons (Avonex, Rebif and Betaferon or Betaseron) belong to a class of messengers that play a role in regulating the immune system. These are used in the treatment of multiple sclerosis.
Interferon-β treatment for multiple sclerosis - PMC
Multiple sclerosis (MS) is the leading nontraumatic cause of neurologic disability in young adults. Interferon-β, approved for use in 1993, was the first treatment to modify the course and prognosis of the disease and remains a mainstay of MS treatment.
Beta interferon - MS Trust
2015年10月1日 · Beta interferon (sometimes referred to as interferon beta), released at the end of an immune attack, blocks the action of gamma interferon and helps to reduce inflammation and the body's immune reaction. Five beta interferon drugs have been developed to treat relapsing multiple sclerosis:
Therapeutic role of beta-interferons in multiple sclerosis
2006年4月1日 · In the last 12 years, there has been a proliferation of studies elucidating the immune mechanisms that mediate tissue damage in MS. Interferons (IFNs) have an important role in regulating innate and adaptive immune responses.